Home › Forums › Main Forum › Generic Medication Access Channels › Pharma’s Market › MYLAN MyHep LVIR

Viewing 3 posts - 16 through 18 (of 18 total)
1 2
  • Author
    Posts
  • 30 December 2015 at 4:54 pm #7566
    avatar876.jpegGaj
    • Guardian Angel
    • ★★★★★
    @gaj

    Yes, particularly as these trials are set up to “prove” the various manufactured DAA pills that are now available instead of the APIs that I, and I believe you, are on.

    But as you say it would be nice if we could put together some sort of database of off trial results for the more ad hoc amongst us. The world map with coloured pins sounded good but not sure how that has progressed?

    G3a since ’78 – Dx ’12 – F4 (2xHCC)
    24wk Tx – PEG/Riba/Dac 2013 relapsed
    24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
    16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
    SVR7 – 22/06/17 UND
    SRV12 – 27/07/17 UND
    SVR24 – 26/10/17 UND
    :cheer: :cheer: :cheer:

    30 December 2015 at 10:11 pm #7582
    Avatar photoVororo
    • Guardian Angel
    • ★★★★★
    @vororo

    Yes, it would be great to know some statistics about all the people who are being treated by – or thanks to – fixHepC.

    How many Australians and how many “foreigners” are now on treatment thanks to fixHepC? How many are UND after the famous 12 week stage? This kind of info could really help to encourage all those guests who come and sit by the pool, but who are still wondering about whether to take the plunge?

    For many of us (why not all?) who have registered here, a lot of the necessary data is already in our signatures.

    [Hmmm, isn’t it just great to sit back and propose even more work for Dr James and his team?]

    …Sorry, James!
    ;)

    Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
    Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
    Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
    Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).

    12 January 2016 at 8:13 am #8755
    tmwhepc
    • Topics: 0
    • Replies: 1
    • Total: 1
    • Novice
    • ★
    @tmwhepc

    http://newsroom.mylan.com/2016-01-07-Mylan-Launches-Generic-Harvoni-Ledipasvir-Sofosbuvir-Under-the-Brand-Name-MyHep-LVIR-in-India

    photo:
    http://photos.prnewswire.com/medias/switch.do?prefix=/appnb&page=/getStoryRemapDetails.do&prnid=20160106%252f319968&action=details

  • Author
    Posts
Viewing 3 posts - 16 through 18 (of 18 total)
1 2
  • You must be logged in to reply to this topic.